Canada markets close in 5 hours 40 minutes

Nabriva Therapeutics plc (NBRV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.4928-0.0172 (-3.37%)
As of 10:19AM EDT. Market open.
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Premium required to access quarterly data
Quarterly

Income Statement

All numbers in thousands
Breakdown
ttm
2019-12-31
2018-12-31
2017-12-31
2016-12-31
Total Revenue
7,008
7,748
6,500
0
0
Cost of Revenue
446
70
-
-
-
Gross Profit
6,562
7,678
-
-
-
Operating Expenses
Research Development
22,247
26,415
82,288
49,615
47,994
Selling General and Administrative
59,746
62,485
41,743
29,472
13,436
Total Operating Expenses
80,472
87,167
120,875
73,768
55,047
Operating Income or Loss
-73,910
-79,489
-114,375
-73,768
-55,047
Interest Expense
3,116
3,644
133
43
75
Total Other Income/Expenses Net
-2,504
215
-272
492
-783
Income Before Tax
-79,277
-82,663
-114,731
-73,001
-55,562
Income Tax Expense
263
101
49
1,355
-672
Income from Continuing Operations
-79,540
-82,764
-114,780
-74,356
-54,890
Net Income
-79,540
-82,764
-114,780
-74,356
-54,890
Net Income available to common shareholders
-79,540
-82,764
-114,780
-74,356
-54,890
Basic EPS
-
-1.12
-2.26
-2.49
-2.56
Diluted EPS
-
-1.12
-2.26
-2.49
-2.56
Basic Average Shares
-
74,199
50,796
29,831
21,478
Diluted Average Shares
-
74,199
50,796
29,831
21,478
EBITDA
-
-78,249
-114,088
-72,526
-55,254